Breast-conserving treatment is equivalent to mastectomy

Comparison of early breast cancer treatment

The number of surgical patients with 5-year recurrence-free survival and overall survival of local recurrence-related death

798 cases of breast-conserving surgery 97.2% 98.3% 1.13% 6 cases

Mastectomy 1380 cases 97.9% 96.3% 1.38% 33 cases

A clinical study of concern: Early breast conserving effect is equivalent to the whole breast removed.

798 cases of breast-conserving surgery

5-year overall survival rate was 98.3%

Breast Center was started in 2000 breast-conserving treatment, follow-up of 798 cases of the implementation of breast-conserving cases, ipsilateral breast local recurrence was found in 9 cases, accounting for 1.13%; ipsilateral supraclavicular lymph node metastasis in 2 cases, accounting for 0.25 %; local recurrence with distal metastasis in 5 cases, accounting for 0.63%; just distal metastasis in 5 cases, accounting for 0.63%; six cases of breast cancer-related deaths (breast cancer-specific mortality rate 0.75%), 3 -year recurrence-free survival rate was 97.8%, and overall survival 99.0%; 5-year recurrence-free survival rate was 97.2%, with a total survival rate of 98.3%.

Over the same period, breast centers are also in the control group 1380 cases of full-mastectomy patients were followed up and found 19 cases of local recurrence, accounting for 1.38%; distal transfer of 58 cases, accounting for 4.2%, breast cancer-related deaths, 33 cases 5-year recurrence-free survival rate was 97.9%, 5-year overall survival rate was 96.3%. Comparing the two, confirming the long-term survival of breast-conserving treatment effect is equivalent to the whole breast removed.

The new clinical practice concern

Central District of breast cancer may also be conserving

In traditional therapy, the Central District of breast cancer tend to take the whole breast removed. Central District, confirmed that breast-conserving therapy, relapse rate was not that high. The new clinical practice in progress, even more concern.

Early cases more suitable for breast-conserving treatment. According to statistics, in the completed-conserving surgery, Ⅰ – Ⅱ patients with breast cancer accounted for 77.69%. With the improved efficacy of systemic adjuvant therapy, early diagnosis of breast cancer not only can reduce the risk of death, but also effectively reduce the treatment costs, so to avoid mastectomy, axillary lymph node dissection and adjuvant chemotherapy opportunity to increase after treatment in patients with breast appearance , upper limb function and systemic conditions closer to the healthy state.

The biggest breast-conserving treatment of patients 83 years of age

Surgical injury and favorable recovery

Clinical practice and research confirms that breast-conserving treatment in patients without age limit. Centers in the breast-conserving therapy patients, the youngest 23 years old, the oldest 83 years old, in which the age of 50 for 512 cases, accounting for 64%; over 50 years a total of 286 cases, accounting for 36%, of which 60 over the age of breast conserving surgery with 103 cases. Elderly breast-conserving injury is small, more conducive to recovery, in developed countries, such a procedure some more. But is not every patient is suitable for breast-conserving treatment.

To launch a new adjuvant chemotherapy

20% of cases after preoperative chemotherapy of breast lesions totally disappeared Center is the first to carry out neo-adjuvant chemotherapy for breast cancer, one of the bodies, many patients will receive training in neo-adjuvant chemotherapy, further surgery. Now completed more than 1,000 cases, about 20% of the cases were preoperative neoadjuvant chemotherapy to achieve lesions completely disappeared; some patients after chemotherapy, tumor regression, but also to breast-conserving surgery.